BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10917652)

  • 1. Structure and mechanism of cytosolic quinone reductases.
    Bianchet MA; Foster C; Faig M; Talalay P; Amzel LM
    Biochem Soc Trans; 1999 Aug; 27(4):610-5. PubMed ID: 10917652
    [No Abstract]   [Full Text] [Related]  

  • 2. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.
    Li R; Bianchet MA; Talalay P; Amzel LM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8846-50. PubMed ID: 7568029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO).
    Bianchet MA; Faig M; Amzel LM
    Methods Enzymol; 2004; 382():144-74. PubMed ID: 15047101
    [No Abstract]   [Full Text] [Related]  

  • 4. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).
    Zhao Q; Yang XL; Holtzclaw WD; Talalay P
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1669-74. PubMed ID: 9050836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A site-directed mutagenesis study at Lys-113 of NAD(P)H:quinone-acceptor oxidoreductase: an involvement of Lys-113 in the binding of the flavin adenine dinucleotide prosthetic group.
    Tedeschi G; Deng PS; Chen HH; Forrest GL; Massey V; Chen S
    Arch Biochem Biophys; 1995 Aug; 321(1):76-82. PubMed ID: 7639539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, function, and mechanism of cytosolic quinone reductases.
    Bianchet MA; Erdemli SB; Amzel LM
    Vitam Horm; 2008; 78():63-84. PubMed ID: 18374190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extramitochondrial reduction of ubiquinone by flavoenzymes.
    Björnstedt M; Nordman T; Olsson JM
    Methods Enzymol; 2004; 378():131-8. PubMed ID: 15038962
    [No Abstract]   [Full Text] [Related]  

  • 8. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places.
    Pey AL; Megarity CF; Timson DJ
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30518535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
    Cavelier G; Amzel LM
    Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of NADPH-dependent ubiquinone reductase activity in rat liver cytosol: effect of various factors on ubiquinone-reducing activity and discrimination from other quinone reductases.
    Takahashi T; Okamoto T; Kishi T
    J Biochem; 1996 Feb; 119(2):256-63. PubMed ID: 8882715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
    Jaiswal AK
    Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p-nitrosophenol reduction by liver cytosol from ADH-positive and -negative deermice (Peromyscus maniculatus).
    Dudley BF; Winston GW
    Arch Biochem Biophys; 1995 Feb; 316(2):879-85. PubMed ID: 7532387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NAD(P)H:quinone acceptor oxidoreductase by flavones: a structure-activity study.
    Chen S; Hwang J; Deng PS
    Arch Biochem Biophys; 1993 Apr; 302(1):72-7. PubMed ID: 8470908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
    Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
    Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the mechanism of Type-II NADH: Quinone oxidoreductase from S. aureus.
    Sena FV; Sousa FM; Oliveira ASF; Soares CM; Catarino T; Pereira MM
    Redox Biol; 2018 Jun; 16():209-214. PubMed ID: 29524843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation compromises FAD binding and intracellular stability of wild-type and cancer-associated NQO1: Insights into flavo-proteome stability.
    Medina-Carmona E; Rizzuti B; Martín-Escolano R; Pacheco-García JL; Mesa-Torres N; Neira JL; Guzzi R; Pey AL
    Int J Biol Macromol; 2019 Mar; 125():1275-1288. PubMed ID: 30243998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase.
    Chen S; Deng PS; Bailey JM; Swiderek KM
    Protein Sci; 1994 Jan; 3(1):51-7. PubMed ID: 7511454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD(P)H:menadione oxidoreductase of the amitochondriate eukaryote Giardia lamblia: a simpler homologue of the vertebrate enzyme.
    Sánchez LB; Elmendorf H; Nash TE; Müller M
    Microbiology (Reading); 2001 Mar; 147(Pt 3):561-570. PubMed ID: 11238963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical and functional perturbation analyses at cancer-associated P187 and K240 sites of the multifunctional NADP(H):quinone oxidoreductase 1.
    Pey AL
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1912-1923. PubMed ID: 30009918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1.
    Moscovitz O; Tsvetkov P; Hazan N; Michaelevski I; Keisar H; Ben-Nissan G; Shaul Y; Sharon M
    Mol Cell; 2012 Jul; 47(1):76-86. PubMed ID: 22793692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.